Semiquantitative GATA-3 Immunoreactivity in Breast, Bladder, Gynecologic Tract, and Other Cytokeratin 7–Positive Carcinomas
Author:
Affiliation:
1. Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA.
Publisher
Oxford University Press (OUP)
Subject
General Medicine
Link
http://academic.oup.com/ajcp/article-pdf/142/1/64/24997418/ajcpath142-0064.pdf
Reference21 articles.
1. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland;Kouros-Mehr;Cell,2006
2. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation;Asselin-Labat;Nat Cell Biol,2007
3. GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas;Cimino-Mathews;Hum Pathol,2013
4. GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value;Voduc;Cancer Epidemiol Biomarkers Prev,2008
5. NY-BR-1 and PAX8 immunoreactivity in breast, gynecologic tract, and other CK7+ carcinomas: potential use for determining site of origin;Woodard;Am J Clin Pathol,2011
Cited by 73 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Case of BRCA2-Pathogenic Variant Breast Cancer With Metachronous Endometrial Cancer and Pancreatic Cancer;World Journal of Oncology;2023-08
2. The Application and Pitfalls of Immunohistochemical Markers in Challenging Diagnosis of Genitourinary Pathology;Archives of Pathology & Laboratory Medicine;2023-04-19
3. A case of BRCA2-pathogenic variant breast cancer with metachronous endometrial cancer and pancreatic cancer: Case report and review of literature;2023-03-10
4. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance;Nature Reviews Gastroenterology & Hepatology;2023-02-08
5. Utility of GATA-3 and associated immunohistochemical markers in the differential diagnosis of poorly differentiated urothelial carcinoma;Journal of Cancer Research and Therapeutics;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3